Safety and efficacy of citalopram in the treatment of premature ejaculation: a double-blind placebo-controlled, fixed dose, randomized study

We evaluate the efficacy and safety of citalopram, a potent and highly selective serotonin reuptake inhibitor (SSRI) antidepressant, in patients with premature ejaculation (PE). In total, 58 potent men with PE were included in the study. Patients were randomly assigned to receive 20 mg oral daily ci...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	International journal of impotence research 2006-03, Vol.18 (2), p.164-169
Hauptverfasser:	Safarinejad, M R, Hosseini, S Y
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Biological and medical sciences Citalopram Citalopram - adverse effects Citalopram - therapeutic use Coitus Complications and side effects Dosage and administration Double-Blind Method Double-blind studies Drug therapy Ejaculation Erectile dysfunction Gynecology. Andrology. Obstetrics Humans Male Male genital diseases Medical sciences Medicine Medicine & Public Health Middle Aged Non tumoral diseases original-article Patient Dropouts - statistics & numerical data Patient Satisfaction Placebos Premature ejaculation Prognosis Reproductive Medicine rology Serotonin Uptake Inhibitors - adverse effects Serotonin Uptake Inhibitors - therapeutic use Sexual disorders Sexual Dysfunction, Physiological - drug therapy Treatment Outcome Urology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!